---  
layout: startup_page  
title: "SpliceBio"  
id: "splice.bio"  
permalink: "/splicebiosplice.bio06112025/"  
website: "http://www.splice.bio/"  
funding_round: "Series B"  
funding_amount: "$135M"  
investors: "EQT Life Sciences, Sanofi Ventures, Roche Venture Fund, New Enterprise Associates, UCB Ventures, Ysios Capital, Gilde Healthcare, Novartis Venture Fund, Asabys Partners"  
about: "SpliceBio is a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes. Their lead program, SB-007, aims to treat Stargardt disease by producing a functional copy of the full-length ABCA4 protein. The companyâ€™s platform leverages engineered proteins (inteins) to overcome the limitations of AAV vectors in delivering large genes."  
markets: "Biotech, Gene Therapy, Ophthalmology, Neurology"  
hq: "Barcelona, Spain"  
founded_year: "2012"  
linkedin: "https://www.linkedin.com/company/splicebio/"  
twitter: "https://twitter.com/SpliceBioHQ"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/proteodesign"  
pitchbook: "https://pitchbook.com/profiles/company/100654-03"  

date_display: "11-Jun-2025"  
date: "2025-06-11"

# SEO Optimization  
meta_title: "SpliceBio - Series B Funding ($135M)"  
meta_description: "SpliceBio, SpliceBio is a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes. Their lead..."  
meta_keywords: "SpliceBio, Biotech, Gene Therapy, Ophthalmology, Neurology, Series B funding"  
canonical_url: "https://startup.projectstartups.com/splicebiosplice.bio06112025/"  
---